The Societal Business Think Tank / Blog

Is this what Larry Fink is searching for?

The Dialysis Rate (DR) is Matrix Economics’ genius. It automatically reduces corporate purification burden as regeneration succeeds. Better EHI/HRI = lower DR = higher α = more token value. A self-reinforcing flywheel that compounds ROI from 24.3% → 42.5%.

The DR Formula – Mathematical Purification

DR = DR₀ × (1 − β × max(IRI, HRI/100))

Variables unpacked:

DR₀ = Initial burden (5% S annually, contractual)
β = Convergence factor (0.15 conservative, 0.10-0.25 range)
IRI = Integrity Index [0,1] (blockchain governance)
HRI = Human Resilience [0,100] (workforce transformation)

Core principle: Genuine system health reduces corporate obligation. Pure incentive alignment.

DR Evolution – Siemens 5-Year Flywheel

Year	EHI	HRI	IRI	max(IRI,HRI/100)	DR (% of S)	α Multiplier	Matrix ROI
0	25	28	0.52	0.52	5.00%	1.20	15.2%
1	42	40	0.65	0.65	4.55%	1.37	24.3%
2	62	55	0.82	0.82	3.94%	1.69	32.1%
3	78	75	0.92	0.92	3.23%	2.25	38.7%
4	85	82	0.97	0.97	2.76%	2.85	42.5%

€15B Siemens S → €42.8B cumulative value (Year 4).

β Sensitivity – Conservative to Aggressive

The convergence control:

β = 0.10 → Gentle (banks, regulators)
β = 0.15 → Baseline (Flynn default) 
β = 0.25 → Aggressive (first movers)

€1B Year 1 impact:

textβ=0.10 → DR=4.70% → α=1.33 → ROI_M=21.8%
β=0.15 → DR=4.55% → α=1.37 → ROI_M=24.3% 
β=0.25 → DR=4.23% → α=1.49 → ROI_M=28.7%

Board choice: β=0.15 delivers 12-20% private credit alpha with conservative assumptions.

HRI vs IRI Dominance – The Binding Constraint

max(IRI, HRI/100) creates natural governance focus:

Siemens Year 1: HRI=40 → HRI/100=0.40, IRI=0.65
max(0.40, 0.65) = **IRI dominates** → Focus governance first

Shell Year 1: HRI=38 → 0.38, IRI=0.62  
max(0.38, 0.62) = **IRI dominates** → Energy governance priority

Pharma Year 1: HRI=45 → 0.45, IRI=0.58
max(0.45, 0.58) = **HRI dominates** → Workforce first

Strategic insight: IRI typically binds early. Companies fix governance → unlock human capital alpha.

DR vs Private Credit – Apples to Apples

€100M annual obligation comparison:

Metric	Private Credit	DR Year 1	DR Year 3	DR Year 5
Annual Cost	€10M (10%)	€4.55M	€3.23M	€2.76M
Token Value Created	€0	€68M	€112M	€142M
Net ROI	10%	24.3%	38.7%	42.5%

DR creates €142M assets while reducing from €10M → €2.76M burden.

Smart Contract DR Implementation

function calculateDR(uint256 hri, uint256 iri) internal returns (uint256) {
    uint256 hriNorm = hri / 100;
    uint256 constraint = hriNorm > iri ? hriNorm : iri;
    return dr0.mul(100 - beta.mul(constraint).div(100));
}

Live triggers:

if (DR < DR₀ * 0.95) {  // 5% improvement
    releaseIncentiveTokens(10% * Q);
}

Global 500 DR Baselines (Conservative)

Industry	DR₀	Year 1 Target	Binding Constraint
Energy	7%	6.2%	IRI (flare reporting)
Industrial	5%	4.55%	IRI (supply chain)
Pharma	4%	3.7%	HRI (clinical trials)
Auto	6%	5.4%	HRI (workforce)

Energy highest DR₀ (complex stranded assets). Pharma lowest (cleaner starting point).

The Compounding Flywheel Effect

Year 1: DR₁=4.55% → α=1.37 → €137M ROI → More regeneration
Year 2: DR₂=3.94% → α=1.69 → €169M ROI → Accelerated regeneration  
Year 3: DR₃=2.78% → α=2.25 → €225M ROI → Exponential

€1B → €5.6B cumulative value (5 years, β=0.15)

Private credit: €1B → €1.6B (same period).

Live calculator:
Flynn Matrix Calculator

---

Is DR the self-optimizing engine BlackRock’s quant team dreams of?